Hypokalemia and ST elevation induced by angiotensin II type 1 receptor blocker and thiazide diuretic combination
Yükleniyor...
Dosyalar
Tarih
2004
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
The combination of an angiotensin II type 1 receptor blocker (valsartan) and a thiazide diuretic (hydrochlorothiazide) has been evaluated in the treatment of patients with hypertension in several clinical trials The valsartan/hydrochlorothiazide (VAL-HCT) combination was found to be generally more effective than either drug given alone. The incidence of adverse events in VAL-HCT recipients was not significantly different than in placebo recipients. Valsartan attenuated the hydrochlorothiazide-associated decrease in serum potassium concentrations. In this report, a 73-year old female patient, who after using VAL-HCT combinations for 1 month, was evaluated with lethargy, restlessness, atypical chest pain, and presyncope at our emergency room. She had ST elevation in D2, D3, aVF, and severe hypokalemia.
Açıklama
Anahtar Kelimeler
Hypokalemia, ST elevation, Valsartan/hydrochlorothiazide
Kaynak
Journal of Applied Research
WoS Q Değeri
Scopus Q Değeri
N/A
Cilt
4
Sayı
3
